Pericarditi, Miocarditi e CMP infiammatorie: cosa c’è di nuovo

Slides:



Advertisements
Similar presentations
Presenter: Massimo Imazio, MD, FESC
Advertisements

M. Lotrionte 1, C. Moretti 2, M. Imazio 3, A. Abbate 4, P. Di Pasquale 5, M. Raatikka 6, A. Brucato 7, I. Sheiban 2, G. Biondi-Zoccai 2 1 Unità di Scompenso.
Chest Infections Lawrence Pike.
Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised.
Genital Herpes Prevention and Clinical Services: What Should Health Departments Do Now? H. Hunter Handsfield, M.D. University of Washington Public Health.
PNEUMONIA Fadi J. Zaben RN MSN.
1 Types of UTI ‘Simple’ or ‘uncomplicated’ –Female –First presentation –No signs of pyelonephritis –Not pregnant ‘Complicated’ –Pregnant –Male –Children.
STENT THROMBOSIS: WHICH IMPACT IN REAL CLINICAL PRACTICE? Giuseppe Biondi Zoccai Divisione di Cardiologia, Università di Torino Ospedale S. Giovanni Battista.
Acute Pericarditis  Incidence – Post mortem 1-6%, diagnosed in only 0.1% of hospitalized patients. 5% of patients seen in emergency rooms with CP and.
Pericardial Disease: Selected Highlights Residents’ Noon Conference 11/12/2009.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
28 June 2011 WHAT PATHOLOGY TESTS TO ORDER WHEN A PATIENT PRESENTS WITH ATYPICAL PNEUMONIA Stephen GRAVES Director Division of Microbiology.
Lower Respiratory Tract Infection. Pneumonia Common with high morbidity and mortality rates. Acute respiratory infection with focal chest signs and radiographic.
Viral Myocarditis and Dilated Cardiomyopathy Kristine Scruggs, MD AM Report 10 March 2010 EdEd.
Clinical Discussant: David B. Pearse, M.D.
Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo- controlled, randomised.
COlchicine for Post-Pericardiotomy Syndrome (COPPS) and Post-Operative Atrial Fibrillation (POAF) prevention study: a multicenter, double-blind randomized.
1 Respiratory Diseases in HIV-infected Patients HAIVN Harvard Medical School AIDS Initiative in Vietnam.
THE DIABETIC FOOT: A MIRROR OF THE DIABETIC HEART Ezio Faglia Chief of research on diabetic foot IRCCS MultiMedica.
Diseases of the Pericardium David L. Hykes, Jr. DO.
Primary Care Conference May 25, 2005 Becky Byers MD Guest patient Charlie Byers PhD.
 Bacteria  Viruses  Fungi  Parasites  Idiopathic.
Serum procalcitonin and C-reactive protein in children with community- acquired pneumonia K.Gogvadze, I.Guramishvili, I.Chkhaidze, K.Nemsadze, T.Maglakelidze.
Agents of neuroinfections
Myocarditis and pericarditis Dr AliM Somily Prof Hanan A Habib.
TABLE Common Causes of Community-Acquired Pneumonia in Patients Who Do Not Require Hospitalization* Mycoplasma pneumoniae Streptococcus pneumoniae.
Bacterial Meningitis - A Medical Emergency Swartz MN N Engl J Med 2004;351:
Patient # 1 = Lab Results Your Results: –CBC: WBC 22 (normal /ul) –BMP: WNL Urine Pregnancy: Neg Head CT: Neg LP: –Cloudy fluid –Opening pressure:
INFECTION CONTROL IN HSCT: USE OF HEPA-FILTER BY IYOHA OSARETIN DEPARTMENT OF MEDICAL MICROBIOLOGY UNIVERSITY OF BENIN TEACHING HOSPITAL BENIN CITY.
Problem 1 (1) A 20-years old student with fever, malaise, headache, diffuculty in sleeping, & healed scar on his arm due to dog bite. Final diagnosis was.
To know more visit HeartFailure.com © 2015 Novartis Pharma AG, May 2015, GLCM/HTF/0028 HEART FAILURE MORTALITY STATISTICS.
Myocarditis Viral (influenza, ECHO, HIV, CMV) Trypanosomiasis (S. American, Chaga’s disease – T cruzi) Non-infective (e.g. eosinophilia associated with.
RESPIRATORY INFECTIONS. World Lung Foundation
Problem 19 (1) A 35-year old man with fever, malaise, & weight loss. Final diagnosis was Fever of Unknown Origin (FUO). Q. What is FUO ?
MICROORGANISMS RELATED TO CARDIAC INFECTIONS Ramlan Sadeli.
Emily O. Jenkins M.D. AM Report
1 Approach to Pulmonary Problems of Immunosuppressed Patients Dr.Özlem Özdemir Kumbasar.
Prevention, Treatment and Care of Hepatitis C among People Who Inject Drugs Jason Grebely, PhD Senior Lecturer Viral Hepatitis Clinical Research Program.
2011 Diagnostic Slide Session Case 7 Aditya Raghunathan Suzanne Z. Powell.
Myocarditis and pericarditis Dr Ali M Somily Prof Hanan A Habib.
Myocarditis and Pericarditis
Community Acquired Pneumonia Peter Valenzuela, MD, MBA, FAAFP Assistant Dean for Clinical Affairs Assistant Professor/Dept. of Family Medicine.
Efficacy of Colchicine When Added to Traditional Anti- Inflammatory Therapy in the Treatment of Pericarditis Efficacy of Colchicine When Added to Traditional.
MYOCARDITIS AND CARDIOMYOPATHIES. DEFINITION Inflammatory disease of the myocardium caused by infectious and noninfectious agents.
Comparison between pathogen directed antibiotic treatment and empiri cal broad spectrum antibiotic treatment in patients with community acquired pneumonia.
Infection following KTP 신장내과 R3 김경엽. Infections Infections Leading cause of morbidity and mortality in the early posttransplant period Leading cause of.
Herpes Simplex Esophagitis. Introduction - Herpes Simplex Virus Double-stranded DNA virus. Epithelial cells are the initial targets. HSV type 1 and 2.
Multifocal Consolidation with Halo Sign 경희대학교 의과대학 감염내과 박기호.
Myocarditis and pericarditis
Community Acquired Pneumonia
Figure 1. Varicella-related outpatient visit rates by age group, MarketScan 2003–2012. Varicella was the primary diagnosis code for data shown. Annual.
Pneumonia Salutations:
Sykdommer i perikard - fokus på behandling
Hannah Jones, PGY-1 Pericarditis.
Blood Culture (Bacterial, Mycobacterial & Fungal)
8th Advances Against Aspergillosis international conference
PCP in adults: Presentation , Treatment and Prophylaxis
Intra-Abdominal Candidiasis, Candida peritonitis
Sensitivity, specificity, positive predictive value, and negative predictive value for the different cutoffs used. Sensitivity, specificity, positive predictive.
8th Advances Against Aspergillosis international conference
PCP: management of co-infection
PCP in adults: Presentation , Treatment and Prophylaxis
Cryptococcal Immune Reconstitution Inflammatory Syndrome
Does your patient have CHF?
Management and risk assessment Highly Infectious Diseases
PCP: management of co-infection
Cryptococcal Immune Reconstitution Inflammatory Syndrome
Myocarditis and Pericarditis
Binge Eating Disorder.
Community Acquired Pneumonia
Presentation transcript:

Pericarditi, Miocarditi e CMP infiammatorie: cosa c’è di nuovo Pericarditi, Miocarditi e CMP infiammatorie: cosa c’è di nuovo? Pericarditi Massimo Imazio, MD, FESC Dipartimento di Cardiologia Ospedale Maria Vittoria, Torino

Pericardite Medico di Guardia

Eziologia, Diagnosi

Imazio M, et al. Circulation. 2007;115:2739

“Everything may cause pericarditis…” Int J Clin Pract 2007; 61: 138 Imazio M et al. Future Cardiology 2007; 3: 623

Major infectious agents Viral (most common: Echovirus and Coxsackievirus (usual), Influenza, EBV, CMV, Adenovirus, Varicella, Rubella, Mumps, HBV, HCV, HIV, Parvovirus B19 and Human Herpes Virus 6 (increasing reports); Bacterial (most common: tuberculous (4-5%), Coxiella burnetii (5-7%?), other bacterial rare may include Pneumo-, Meningo-, Gonococcosis, Haemophilus, Staphylococci, Chlamydia, Mycoplasma, Legionella, Leptospira, Listeria) Fungal (rare: Histoplasma more likely in immunocompetent patients, Aspergillosis, Blastomycosis, Candida more likely in immunosuppressed host) Parasitary (very rare: Echinococcus, Toxoplasma) SYSTEMATIC BATTERY OF SEROLOGICAL TESTS Levy PY et al.Future MIcrobiol 2006; 1(2):229

Acute pericarditis: etiology Imazio M, et al. Circulation. 2007;115:2739 Imazio M, Trinchero R. Future Cardiology 2007; 3: 623

Triage in acute pericarditis

Diagnostic criteria Imazio M, Trinchero R. J Cardiovasc Med 2007; 8: 404

Etiologic screening

Am J Cardiol 2007; 99: 1294-7

Pathogenesis of recurrences Imazio M, Trinchero R. Future Cardiology 2007; 3: 623

Etiology of recurrent pericarditis

Terapia

ASA o FANS Aspirina 2-4g/die Ibuprofene 1200-1800mg/die Indometacina Nimesulide 200mg/die Imazio M et al. J Cardiovasc Med 2007; 8: 748

Corticosteroidi come FR per le recidive Imazio M, Trinchero R Rec Prog Med 2006; 98(5):265-70 Imazio M, et al. Circulation. 2007;115:2739

Effetti collaterali gravi Recidive Ricoveri Prednisone Effetti collaterali gravi Recidive Ricoveri 1mg/Kg/die 25% ++ 0.2-0.5mg/Kg/die <10% + Nature Cardiovasc Med 2008; in press

Cleve Clin J Med 2007; 74: 385-6

COPE: COlchicine for acute PEricarditis NNT= 5 Corticosteroid therapy: Recurrences OR 4.30 95% CI 1.21 to 15.25; p=0.024 Here we can see the main results of the study. The primary end point was the recurrence rate. Colchicine reduced the recurrence rate at 18 months down to 11% and was also able to reduce the symptoms persistence at 72 hours as it can be observed in pts with a gouty attack. Drug withdrawal was recorded in about 8% of cases due to diarrhea. Thus in this study we need to treat 5 pts with colchicine in order to prevent 1 recurrence. In multivariate analysis, corticosteroid therapy was an independent risk factor for recurrences. Drug withdrawal Imazio M et al. Circulation 2005; 112(13):2012-6.

Colchicina e recidive Imazio M, Trinchero R Rec Prog Med 2006; 98(5):265-70

Colchicina e storia naturale della pericardite recidivante Attack rate Rec/pt/month Brucato A et al. Clin Exp Rheumatol. 2006;24(1): 45-50

Colchicine: How does it work? Imazio M, Trinchero R. Future Cardiology 2007; 3: 623

Imazio M, Trinchero R. Future Cardiology 2007; 3: 623

Colchicina e pericardite: Trials in corso Imazio M et al. JCM 2007; Dic; 8(12):1044-8 Imazio M et al. JCM 2007; Oct;8(10):830-4 Imazio M et al. JCM 2007; Aug;8(8):613-7.

Clin Sci 2007; 113(11):443-8

JCM 2007; 8: 748-53

Prognosi

Am J Cardiol 2007; 100:1026

MOST CASES ARE BENIGN, TRIAGE FOR DECISION-MAKING MD on duty